Pfizer
Utility Patent Applications
Last updated:
List of all Pfizer patents 264 in total
| Status | Patent |
|---|---|
Application | Utility: GLP-1 Receptor Agonists and Uses Thereof Filling date: 13 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: IL-15 Variants and Uses Thereof Filling date: 13 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: Dosage Regimen For MAdCAM Antagonists Filling date: 13 Sep 2025 Issue date: 21 Oct 2021 |
Application | Utility: SOLID DOSAGE FORMS OF PALBOCICLIB Filling date: 13 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITORS Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: 5,7-DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: SUBSTITUTED 3-AZABICYCLO[3.1.0]HEXANES AS KETOHEXOKINASE INHIBITORS Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: Heterocyclic Spiro Compounds As MAGL Inhibitors Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: HETEROARYL SULFONE-BASED CONJUGATION HANDLES, METHODS FOR THEIR PREPARATION, AND THEIR USE IN SYNTHESIZING ANTIBODY DRUG CONJUGATES Filling date: 13 Sep 2025 Issue date: 7 Oct 2021 |
Application | Utility: HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS Filling date: 13 Sep 2025 Issue date: 30 Sep 2021 |
Application | Utility: CDK2 INHIBITORS Filling date: 13 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: SOLID STATE FORMS OF (S)-2-(((S)-6,8-DIFLUORO-1,2,3,4-TETRAHYDRONAPHTHALEN-2-YL)AMINO)-N-(1-(2- -METHYL-1-(NEOPENTYLAMINO)PROPAN-2-YL)-1H-IMIDAZOL-4-YL)PENTANAMIDE AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: PHARMACEUTICAL AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPH- OLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA Filling date: 13 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: CDK2 INHIBITORS Filling date: 13 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making And Using Same Filling date: 13 Sep 2025 Issue date: 26 Aug 2021 |
Application | Utility: METHODS OF TREATING CANCER USING COMBINATION THERAPY Filling date: 13 Sep 2025 Issue date: 19 Aug 2021 |
Application | Utility: ANTI-E-SELECTIN ANTIBODIES, COMPOSITIONS AND METHODS OF USE Filling date: 13 Sep 2025 Issue date: 12 Aug 2021 |
Application | Utility: Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) Filling date: 13 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: RECOMBINANT ROBO2 PROTEINS, COMPOSITIONS, METHODS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPH- OLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA Filling date: 13 Sep 2025 Issue date: 15 Jul 2021 |
Application | Utility: N-SUBSTITUTED-DIOXOCYCLOBUTENYLAMINO-3-HYDROXY-PICOLINAMIDES USEFUL AS CCR6 INHIBITORS Filling date: 13 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: STABILITY-MODULATING LINKERS FOR USE WITH ANTIBODY DRUG CONJUGATES Filling date: 13 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: ORAL SOLUTION FORMULATION Filling date: 13 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof Filling date: 13 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: Methods of Treating Metabolic Disease Filling date: 13 Sep 2025 Issue date: 1 Jul 2021 |
Application | Utility: THERAPEUTIC ANTIBODIES AND THEIR USES Filling date: 13 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: Chemical Compounds Filling date: 13 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: ANTI-PROLIFERATIVE AGENTS FOR TREATING PAH Filling date: 13 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making and Using Same Filling date: 13 Sep 2025 Issue date: 24 Jun 2021 |
Application | Utility: THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING THE SAME Filling date: 13 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: MEDIA AND FERMENTATION METHODS FOR PRODUCING POLYSACCHARIDES IN BACTERIAL CELL CULTURE Filling date: 13 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: Antibodies Specific for CD47, PD-L1, and Uses Thereof Filling date: 13 Sep 2025 Issue date: 17 Jun 2021 |
Application | Utility: GLP-1 Receptor Agonists and Uses Thereof Filling date: 13 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: INTERFERON BETA ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 3 Jun 2021 |
Application | Utility: GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: APIXABAN FORMULATIONS Filling date: 13 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: STABLE AQUEOUS ANTIBODY FORMULATION Filling date: 13 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF Filling date: 13 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: ENGINEERED POLYPEPTIDE CONJUGATES AND METHODS FOR MAKING THEREOF USING TRANSGLUTAMINASE Filling date: 13 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: METHODS OF GLYCOENGINEERING PROTEOGLYCANS WITH DISTINCT GLYCAN STRUCTURES Filling date: 13 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: COMPOSITIONS COMPRISING HETEROGENEOUS POPULATIONS OF RECOMBINANT HUMAN CLOTTING FACTOR XA PROTEINS Filling date: 13 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS Filling date: 13 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: AQUEOUS PHARMACEUTICAL FORMULATION COMPRISING ANTI-PD-L1 ANTIBODY AVELUMAB Filling date: 13 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: ANTI-CXCR5 ANTIBODIES AND COMPOSITIONS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: DIACYLGLYCEROL ACYL TRANSFERASE 2 INHIBITOR Filling date: 13 Sep 2025 Issue date: 8 Apr 2021 |
Showing 50 to 100 of 264 patents.